Suhan Ni

Array ( [id] => 5944882 [patent_doc_number] => 20110105502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'TETRAHYDROISOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/933326 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45280 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105502.pdf [firstpage_image] =>[orig_patent_app_number] => 12933326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7530484 [patent_doc_number] => 07842706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 12/382691 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8233 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842706.pdf [firstpage_image] =>[orig_patent_app_number] => 12382691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870799 [patent_doc_number] => 08466176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Fungicide hydroximoyl-tetrazole derivatives' [patent_app_type] => utility [patent_app_number] => 12/933276 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42689 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12933276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685092 [patent_doc_number] => 20130053376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'NOVEL TYROSINE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/922891 [patent_app_country] => US [patent_app_date] => 2009-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38808 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9127244 [patent_doc_number] => 08575193 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds' [patent_app_type] => utility [patent_app_number] => 12/921821 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20250 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12921821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458683 [patent_doc_number] => 20090258835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/403143 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14293 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258835.pdf [firstpage_image] =>[orig_patent_app_number] => 12403143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257715 [patent_doc_number] => 08207194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Compounds having a 4-pyridylalkylthio group as a substituent' [patent_app_type] => utility [patent_app_number] => 12/381290 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55003 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12381290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485986 [patent_doc_number] => 20090275751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => '1,2-DIHYDROPYRIDINE COMPOUNDS, MANUFACTURING METHOD THEREOF AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/395378 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75918 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275751.pdf [firstpage_image] =>[orig_patent_app_number] => 12395378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097989 [patent_doc_number] => 20110003859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'N- (6-AMINOPYRIDIN-3-YL) -3- (SULFONAMIDO) BENZAMIDE DERIVATIVES AS B-RAF INHIBITORS FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/919972 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21583 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003859.pdf [firstpage_image] =>[orig_patent_app_number] => 12919972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113217 [patent_doc_number] => 20110190263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/918803 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25440 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190263.pdf [firstpage_image] =>[orig_patent_app_number] => 12918803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351846 [patent_doc_number] => 20100331312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'MODULATORS OF THE HISTAMINE H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 12/867570 [patent_app_country] => US [patent_app_date] => 2009-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 44796 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331312.pdf [firstpage_image] =>[orig_patent_app_number] => 12867570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5423047 [patent_doc_number] => 20090149503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'NEW 5-ARYL PYRIDINES AS 11-BETA INHIBITORS FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 12/372244 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23211 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149503.pdf [firstpage_image] =>[orig_patent_app_number] => 12372244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546758 [patent_doc_number] => 20090156635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS' [patent_app_type] => utility [patent_app_number] => 12/371681 [patent_app_country] => US [patent_app_date] => 2009-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22632 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156635.pdf [firstpage_image] =>[orig_patent_app_number] => 12371681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480672 [patent_doc_number] => 20090203629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'INHIBITORS OF CATHEPSIN B' [patent_app_type] => utility [patent_app_number] => 12/366504 [patent_app_country] => US [patent_app_date] => 2009-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23549 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203629.pdf [firstpage_image] =>[orig_patent_app_number] => 12366504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305952 [patent_doc_number] => 08227489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 12/358639 [patent_app_country] => US [patent_app_date] => 2009-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11370 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12358639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380361 [patent_doc_number] => 20090192200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'POLYMORPHS OF SORAFENIB TOSYLATE AND SORAFENIB HEMI-TOSYLATE, AND PROCESSES FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/356004 [patent_app_country] => US [patent_app_date] => 2009-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7104 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192200.pdf [firstpage_image] =>[orig_patent_app_number] => 12356004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343356 [patent_doc_number] => 20090182006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Salt of naphthyridine carboxylic acid derivative' [patent_app_type] => utility [patent_app_number] => 12/318845 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6818 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20090182006.pdf [firstpage_image] =>[orig_patent_app_number] => 12318845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558885 [patent_doc_number] => 20090270462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => '2-SULFANYL-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE AS CYTOKINE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/347498 [patent_app_country] => US [patent_app_date] => 2008-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18587 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270462.pdf [firstpage_image] =>[orig_patent_app_number] => 12347498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6577098 [patent_doc_number] => 20100273827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (S1p)' [patent_app_type] => utility [patent_app_number] => 12/747191 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13746 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273827.pdf [firstpage_image] =>[orig_patent_app_number] => 12747191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386226 [patent_doc_number] => 08263620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Oxadiazole derivatives active on sphingosine-1-phosphate (SIP)' [patent_app_type] => utility [patent_app_number] => 12/747188 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15046 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747188 [rel_patent_id] =>[rel_patent_doc_number] =>)